KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Fulgent Genetics (FLGT) Leases (2019 - 2025)

Fulgent Genetics' Leases history spans 7 years, with the latest figure at $5.0 million for Q4 2025.

  • For Q4 2025, Leases rose 543.45% year-over-year to $5.0 million; the TTM value through Dec 2025 reached $5.0 million, up 543.45%, while the annual FY2025 figure was $5.0 million, 543.45% up from the prior year.
  • Leases for Q4 2025 was $5.0 million at Fulgent Genetics, up from $423000.0 in the prior quarter.
  • Across five years, Leases topped out at $18.0 million in Q2 2022 and bottomed at $47000.0 in Q3 2021.
  • The 5-year median for Leases is $2.4 million (2021), against an average of $4.8 million.
  • The largest annual shift saw Leases plummeted 98.25% in 2021 before it soared 6304.26% in 2022.
  • A 5-year view of Leases shows it stood at $1.7 million in 2021, then surged by 752.1% to $14.8 million in 2022, then crashed by 91.1% to $1.3 million in 2023, then plummeted by 41.41% to $771000.0 in 2024, then soared by 543.45% to $5.0 million in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Leases are $5.0 million (Q4 2025), $423000.0 (Q3 2025), and $4.8 million (Q2 2025).